Metastasiertes Prostatakarzinom: Verbessert Prostatabestrahlung die Prognose?
- PMID: 31398751
- DOI: 10.1055/a-0890-7971
Metastasiertes Prostatakarzinom: Verbessert Prostatabestrahlung die Prognose?
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Comment on
-
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.Lancet. 2018 Dec 1;392(10162):2353-2366. doi: 10.1016/S0140-6736(18)32486-3. Epub 2018 Oct 21. Lancet. 2018. PMID: 30355464 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources